JohnCraryMD

Neuropathology, Anatomic Pathology, Clinical Pathology

Associate Professor, Icahn School of Medicine at Mount Sinai

Dr. Crary is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuropathology, 2008 - 2010
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2006 - 2008
SUNY Downstate Medical CenterPh.D., Neural & behavioral science, 1997 - 2006
State University of New York Downstate Medical Center College of MedicineClass of 2006
Brown UniversitySc.B., Neuroscience, with Honors, 1992 - 1996

Alexander Saint-Amand Scholar 2016
Louis V. Gerstner, Jr. Scholar 2011
SUNY Chancellor’s Award for Student Excellence 2006
Medical Student Prize for Excellence in Neurology American Academy of Neurology, 2006
Chancellor’s Award for Student Excellence SUNY, 2006
Award for Excellence in Pathology SUNY Downstate, 2006
Pine Family Foundation Scholar 2001
Research Fellowship SUNY Downstate Alumni Association, 1998
Join now to see all

PubMed

Lectures

Tautologies & Tau
University of California San Diego - 1/1/2017
Age-related tauopathy: Clinical, genetic and molecular studies.
1/1/2017
Refining the neuropathological criteria for Alzheimer's disease
New York, NY - 1/1/2016
Refining the neuropathological criteria for Alzheimer’s disease
Mayo Clinic, Jacksonville, FL - 1/1/2014
Refining the neuropathological criteria for Alzheimer’s disease.
SUNY Downstate Medical Center, New York, NY - 1/1/2014
Neuroscience of Sports: Your Brain in Action
American Museum of Natural History - 1/1/2013
Tautologies and Tau: Defining Alzheimer’s Disease Subtypes
NYU School of Medicine - 1/1/2013
Join now to see all

Mount Sinai Researchers Use Artificial Intelligence to Uncover the Cellular Origins of Alzheimer’s Disease and Other Cognitive DisordersSeptember 20th, 2022
AI Platform Shows Potential in Diagnosing Patients at Early StagesApril 28th, 2022
PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s DiseaseApril 20th, 2022
Join now to see all

: Regulation of tau expression in Alzheimer disease and agingNIH/NIA2016–2021
Mechanisms of age-related tauopathyNIH/NIA2015–2020
Clinical-Pathological Study of Cognitive Impairment in ETNIH/NINDS2014–2019
Molecular & genetic investigation of tau in CTEDepartment of Defense2014–2019
Aptamer-based bioactuators for early diagnosis of ADSaint-Amand Research Scholar Award2016–2017
Career Development in the Neuropathology of ADNIH/NIA2015–2017
Regulation of tau expression and toxicity by miR-219Rainwater Foundation2015–2017
Neuropathological characterization of PARTAlzheimer's Association2015–2017